Boston Scientific announced Thursday it will purchase cardiac monitoring company Preventice Solutions in a $925 million deal, putting it directly into the fast-growing cardiac monitoring industry. The deal, the second in the space this week, is expected to close by mid-2021.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,